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CYTOKINE INFLAMMATORY SCORE PREDICTS PREGNANCY OUTCOME IN WOMEN 
WITH MIDTRIMESTER SHORT CERVIX
































	 	 -	 	Singleton	pregnancies
	 	 -	 Gestational	age	16-24	weeks
	 	 -	 Transvaginal	cervical	length	of	<25mm
	 	 -	 	Patients	who	received	no	surgical	or	hormonal	treatment	for	short	cervix
	 	 -	 	No	known	fetal	chromosomal	or	structural	abnormality,	vaginal	bleeding,	or	ruptured	
membranes



























	 	 -	 	77%	sensitivity,	100%	specificity,	100%	PPV,	81%	NPV	for	delivery	<32	weeks.





















Maternal Age (yrs) 30 (16-41) 24 (16-35) 0.11
Parity 1 (0-3) 0.5 (0-2) 0.03
Gestational Age at 
Admission (weeks)




16 (0-25) 0 (0-55) <0.0001
AF Glucose 41 (22-63) 25.8 (1-40) 0.003




116 (92-129) 4 (2-14) <0.0001
pPROMn (%) 4 (15.4%) 10 (55.6%) 0.007
Gestational Age at 
Delivery (weeks) 38 (34-39) 23 (21-25) <0.0001
*    Wilcoxon Rank-Sum for continuous data; Fisher’s Exact for proportions
**  Data are presented as median (range)
***Data are presented as median (interquartile range) or n(%)
Figure 1. Distribution of AF Cytokine 
Inflammatory Score
Table 1. Univariate Analysis




Lower limit of 
detection 
(pg/ml)
% of samples 
below level of 
detection
Delivery within 28 
days
Delivery before 34 
weeks
Cytokines with >25% undetected; 1 point given for each cytokine if level was >2 times the lower limit of detection
IL-1β 0.9 0.8 47.7 21.60 (1.81 - 258.13) 40.00 (2.65 - 604.53)
IL-2 1.4 1.1 47.7 5.67 (0.73 - 43.99) 6.00 (0.75 - 48.15)
IL-4 0.5 0.5 52.3 6.33 (0.72 - 55.96) 7.80 (0.76 - 79.72)
IL-5 0.8 0.8 93.2 NE NE
IL-10 1.1 0.9 45.5 17.00 (1.51 - 191.60) 15.20 (1.49 - 155.14)
IL-12 1.1 0.5 27.3 17.00 (1.51 - 191.60) 15.20 (1.49 - 155.14)
IL-13 2.1 2.1 86.4 6.87 (0.20 - 235.51) 5.56 (0.16 - 189.69)
IL-15 6.6 4.2 27.3 12.04 (1.26 - 115.26) 11.52 (1.25 - 106.52)
IL-17 0.2 0.2 61.4 70.40 (2.05 ->999.99) NE
Eotaxin 18.2 14.6 36.4 7.08 (0.87 - 57.45) 7.31 (0.88 - 60.56)
MIP-1α 2.4 2.1 59.1 93.50 (2.56 - >999.99) NE
TNF-α 3.0 3.0 68.2 35.74 (1.13 - >999.99) NE
VEGF 4.7 0.5 27.3 2.13 (0.29 - 15.74) 2.46 (0.32 - 19.09)
Cytokines levels in upper quartaile were predictive of delivery; 1 point given for each cytokinein upper quartile
IL-6 515.9 1.1 4.6 26.92 (1.76 - 411.03) 21.33 (1.78 - 255.52)
IL-8 576.7 0.5 6.8 17.00 (1.51 - 191.60) 15.20 (1.49  155.14-)
G-CSF 308.4 1.1 4.6 26.92 (1.76 - 411.03) 21.33 (1.78 - 255.52)
INF-γ 86.6 19.3 2.3 9.00 (1.04 - 78.10) 9.71 (1.06 - 89.07)
MCP-1 539.1 6.7 2.3 45.71 (1.43 - >999.99) 70.40 (2.05 - >999.99)
MIP-1β 60.2 1.1 4.6 13.71 (1.27 - 48.45) 21.33 (1.78 - 255.52)
RANTES 20.2 1.2 2.3 17.00 (1.51 - 191.60) .20 (1.49 - 155.14)
Cytokines detected in most patients, but were not predictive of delivery; No points were given for these cytokines
IL-1ra 5414.3 1.4 4.6 3.71 (0.517 - 26.69) 6.00 (0.75 - 48.15)
IL-7 3.9 0.5 13.6 2.92 ( 0.325 - 26.25) 2.27 (0.26 - 20.17)
IL-9 17.1 0.7 4.6 3.71 (0.52 - 26.69) 6.00 (0.748 - 48.15)
IL-10 26147.2 6.5 4.6 0.89 (0.10 - 7.670) 1.129 (0.130 - 9.78)









1Stony Brook-Winthrop University Hospitals, Long Island, New York; 2Naval Medical Center Portsmouth, Portsmouth, Virginia; 3Winthrop University Hospital, Miineola, New York; 4Lehigh Valley Health Network, Allentown, Pennsylvania
Figure 2. Correlation of AF Cytokine 
Score with Cervical Length
Figure 3. Kaplan-Meier Pregnancy 
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